Thorium

Thorium occurs naturally in soil, food, water, and airborne dust, so small amounts can reflect ordinary background exposure. Mining and processing thorium-bearing minerals can create higher exposures. Finding thorium in blood does not identify where it came from or establish that it has harmed you.

Whole-blood thorium is an exploratory exposure marker. Researchers have published population measurements, but there are no validated blood concentrations that predict toxicity, cancer risk, or a need for treatment. Its usefulness for routine preventive screening has not been established.

What Your Blood Level Reflects

This test measures thorium in whole blood using ICP-MS. This laboratory method detects very small amounts of individual elements. The result reports the amount of metal in the sample; estimating radiation dose requires information about the radioactive forms present, where they are retained, and how long they remain there.

Only a small fraction of swallowed thorium enters the bloodstream. Absorption of inhaled thorium depends on the compound and particle size. Some material can remain in the lungs and nearby lymph nodes, while absorbed thorium can accumulate in bone. Human tissue studies have found retained thorium in former workers long after exposure ended.

Blood samples capture the circulating fraction, which is affected by absorption, movement into tissues, and release from retained material. A low result cannot exclude old deposits or substantial exposure to poorly soluble dust. A higher result cannot establish when exposure happened.

A study of Australian mineral-sands workers measured thorium in serum and urine, which are different specimens from whole blood. Neither measurement correlated with cumulative airborne exposure. That finding limits how confidently these measurements can be used to reconstruct a person's exposure history.

Where Exposure Comes From

Environmental studies identify possible sources, but their air, water, and food measurements do not establish what a particular blood result means.

• Mining and rare-earth processing: thorium occurs in minerals such as monazite. Measurements around a major Chinese rare-earth mining and smelting area found airborne thorium concentrations far above the worldwide reference used in that study. Researchers also estimated inhalation doses from personal air sampling; they did not measure residents' blood thorium.
• Coal-related contamination: a Serbian groundwater study measured thorium, uranium, and other elements near coal-fired power plants. It modeled potential health risks from the mixture. Those estimates were not observed cases of illness and cannot be translated into risk from a blood thorium result.
• Food and drinking water: a study in central Poland measured radioactive elements in food and water and estimated dietary intake. About 72% of the calculated radiation dose from the elements studied came from radium-226. That percentage described the combined dietary exposure, not the dose from thorium alone.
• Local geology and contaminated sites: exposure can be higher near thorium-bearing deposits or facilities that process them. Thorium tends to attach to particles and sediment, so the amount in drinking water depends on local conditions.

What Population Studies Show

A study of 305 healthy adults in and around Belgrade measured whole-blood thorium by ICP-MS. Women had higher concentrations than men, and adults under 40 had higher concentrations than older adults. These were differences within one population, not evidence that either group had thorium-related disease.

The study reported thorium and uranium concentrations up to 100 times higher than published measurements from some other populations. Cross-study differences can reflect exposure, collection materials, and laboratory methods. They do not establish that geography alone explains the difference, or that a concentration common in one population is safe.

The age finding also does not show how thorium moves into organs as you get older. The study measured different people at one point in time and did not follow their blood levels or tissue deposits through life.

Lung Disease and Cancer in Exposed Workers

A Chinese follow-up study reported higher lung cancer mortality and more early chest X-ray changes suggestive of dust-related lung disease among exposed miners than controls. Lung deposits were estimated in 638 miners using exhaled radioactive decay products. The dust contained thorium and silica, and exposure also included radioactive decay products, which makes thorium's separate contribution difficult to determine.

An early study of 3,039 male thorium-processing workers found more deaths than expected from lung cancer, pancreatic cancer, and respiratory diseases. The increases for these outcomes in the full cohort were statistically uncertain. Pancreatic cancer mortality was significantly higher in a smaller subgroup with jobs considered more highly exposed, though smoking and other workplace exposures complicated interpretation.

A later follow-up of the processing workforce found a statistically significant increase in lung cancer mortality among men, but the available employment-related measures did not establish a clear exposure-response relationship. These studies support concern about prolonged exposure to the workplace mixture. They did not establish a relationship between whole-blood thorium and cancer risk.

Liver Cancer and Leukemia After Thorotrast

The strongest human evidence of harm comes from Thorotrast. This historical X-ray contrast agent contained thorium dioxide and was injected into blood vessels. Its particles remained mainly in the liver, spleen, and bone marrow, creating prolonged internal radiation exposure.

An international study followed 3,042 people after imaging of the brain's blood vessels. Of those, 1,650 received Thorotrast; the others received a nonradioactive contrast agent. The Thorotrast group had substantial excesses of liver, bile duct, and gallbladder cancers and leukemia. Evidence for a pancreatic cancer association was less certain. The German Thorotrast study also documented increased cancers of the liver and blood-forming tissues.

These findings establish the danger of retained, injected thorium dioxide. The route, chemical form, and amount of exposure were very different from ordinary environmental exposure. They cannot supply a cancer-risk estimate for a trace whole-blood measurement.

Heart Disease

An older review of human and animal evidence found no apparent support for thorium as a cause of endomyocardial fibrosis. This disease scars the heart's inner lining. That limited evidence does not rule out every possible cardiovascular effect, and blood thorium has not been validated for estimating heart disease risk.

When Results Can Be Misleading

At the very small concentrations being measured, collection and analytical errors can materially change the result.

• Collection contamination: studies have found thorium contamination from blood collection materials. Tube suitability matters even when a product is intended for trace-element testing. Contamination is a possible explanation for an unexpected result, but it has not been established as the most common explanation.
• Measurements near the detection limit: instrument background, sample preparation, and small amounts of contamination can make small differences between results difficult to interpret. An undetectable result means the amount was below the method's detection capability.
• Thorium retained outside blood: a low circulating concentration can coexist with material retained in lungs, lymph nodes, or bone.
• Different specimens and laboratories: whole blood, serum, and urine measure different fractions. Differences in collection, analytical sensitivity, and calibration can also affect comparisons between laboratories.
• Population comparisons: published background distributions describe the people sampled. They are not health-based boundaries between safe and harmful exposure.

What a Trend Can Show

Repeated measurements under comparable conditions may help document whether the circulating concentration changes during an exposure investigation. There is no validated change in whole-blood thorium that proves exposure is controlled or that future health risk has fallen.

A falling result can reflect reduced absorption, movement out of blood, or measurement variation. It does not demonstrate removal of thorium already retained in organs. Interpretation needs the exposure history and, when relevant, measurements of the suspected source.